Toxicology of silica nanoparticles: an update.

Murugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F, Sebaihi N, Hoet PH. · 2017

Read Toxicology of silica nanoparticles: an update. by Murugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F, Sebaihi N, Hoet PH. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5562771.txt.

Introduction

Murugadoss and co-authors update the toxicology of silica nanoparticles in Archives of Toxicology. Amorphous silica particles now fill foods, cosmetics, and farm products. Human exposure keeps rising with production. Their health effects stay unsettled.

The review sorts studies from 2010 to 2016. In cell tests, harm depended on size, dose, and cell type. How particles were made mattered too. Wet-route and thermal-route products behaved differently. Some amorphous types harmed cells much like crystalline silica. In animals, harm showed mainly after acute exposure. Chronic dosing produced few clear signs. Lab and animal results still line up poorly. Unrealistic dosing in both settings muddies the match. No firm link yet ties particle traits to human risk. Readers get an honest map of a large, unresolved literature.

Catalog record

CREATORMurugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F, Sebaihi N, Hoet PH.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE88 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5562771

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Toxicology of silica nanoparticles: an update By Sivakumar Murugadoss, Dominique Lison, Lode Godderis, Sybille Van Den Brule, Jan Mast, Frederic Brassinne, Noham Sebaihi, Peter H Hoet Published in: Archives of Toxicology DOI: 10.1007/s00204-017-1993-y ABSTRACT Abstract Large-scale production and use of amorphous silica nanoparticles (SiNPs) have increased the risk of human exposure to SiNPs, while their health effects remain unclear. In this review, scientific papers from 2010 to 2016 were systematically selected and sorted based on in vitro and in vivo studies: to provide an update on SiNPs toxicity and to address the knowledge gaps indicated in the review of Napierska (Part Fibre Toxicol 7:39, 2010). Toxicity of SiNPs in vitro is size, dose, and cell type dependent. SiNPs synthesized by wet route exhibited noticeably different biological effects compared to thermal route-based SiNPs. Amorphous SiNPs (particularly colloidal and stöber) induced toxicity via mechanisms similar to crystalline silica. In vivo, route of administration and physico-chemical properties of SiNPs influences the toxicokinetics. Adverse effects were mainly observed in acutely exposed animals, while no significant signs of toxicity were noted in chronically dosed animals. The correlation between in vitro and in vivo toxicity remains less well established mainly due to improper—unrealistic—dosing both in vitro and in vivo. In conclusion, notwithstanding the multiple studies published in recent years, unambiguous linking of physico-chemical properties of SiNPs types to toxicity, bioavailability, or human health effects is not yet possible. Keywords: Amorphous silica nanoparticles, Pyrogenic, Colloidal, Stöber, Oxidative stress, Toxicity INTRODUCTION Nanosilica, also known as the nanoform (<100 nm) of silicon dioxide or silica nanoparticles (SiNPs), possesses distinct physico-chemical characteristics compared to its bulk form; smaller size materials have an increased surface-to-volume ratio and a higher surface reactivity (Oberdörster 2010; Napierska et al. 2010). Due to their appealing properties, SiNPs are now extensively used in agriculture, food, and consumer products including cosmetics (Napierska et al. 2010; Khot et al. 2012; Kasaai 2015; Brinch et al. 2016). Until 2012, nearly 1.5 million tons of SiNPs had already been placed in the global market (Liljenström et al. 2013) and SiNPs became one of the three most produced nanomaterials (NMs) worldwide in 2013. Among the 846 nano-based products listed in a consumer products inventory, approximately 100 claim to contain SiNPs (Vance et al. 2015). Moreover, amorphous SiNPs are being synthesized with highly tunable biocompatibility and stability, and considered as a very promising candidate for various bio-medical applications such as gene carrier, drug delivery, and molecular imaging (Tang and Cheng 2013; Bitar et al. 2012). In recent years, large-scale industrial production and global commercialization of SiNPs have resulted in increased risk of human exposures at workplaces (Kim et al. 2014a; Oh et al. 2014). Food additive silica (E551) is also in the nano size range (Dekkers et al. 2011), indicating that the general population is probably more exposed than initially anticipated. Moreover, in view of the efforts to use NM in medical applications, SiNPs could also be intentionally introduced into the human body for disease diagnosis and treatments (Croissant et al. 2017). Such growing potentials for exposure raised a global concern regarding the safety and potential adverse health effects of SiNPs. Human health effects associated with silica exposure, especially crystalline silica (0.5–10 µm), have widely been studied. Occupational exposure to crystalline silica induces silicosis in workers (a fibrotic lung disease) and is also associated with lung cancer, emphysema, and pulmonary tuberculosis (Leung et al. 2012). Conversely, natural amorphous silica is generally considered as less harmful, since the toxicological potential of silica has so far been linked to its crystallinity. Recent studies have revealed that amorphous SiNPs can be as reactive as crystalline particles (Turci et al. 2016). In vivo, amorphous SiNPs are, however, cleared more rapidly from the lung, which may contribute to explain their lower pathogenic potential (Arts et al. 2007). The human health effects of nanosilica remain to be clarified and toxicologists believe that exposure to SiNPs, due to their small size, may bring different adverse effects compared to micron-sized silica (Napierska et al. 2010). The comprehensive review of Napierska et al. (2010) suggested that exposure to SiNPs (1–100 nm) induced toxic effects in vitro (immortalized mammalian cell lines) and in vivo (rats and mice). Physico-chemical properties such as size, surface area, and surface features were found to play a key role in the toxicity of SiNPs. Importantly, Napierska concluded that physico-chemical properties of SiNPs differ based on their production method and, therefore, may cause different biological effects. However, no definite conclusions were made due to insufficient or no data available for, - Detailed physico-chemical characterization of different types of SiNPs; - Comparison of the toxicity of different types of SiNPs (based on their production process); - Comparison of the toxicity mechanisms of amorphous SiNPs and crystalline silica; - Exposure via different routes and adverse effects of chronic exposure in vivo; - Correlation of in vitro and in vivo studies and - Physico-chemical properties for the safer design of SiNPs. Therefore, the aim of this review is to summarize the toxicity studies of SiNPs published after the Napierska review (2010), critically discuss the outcomes, and to evaluate how these data gaps have been addressed (Fig. 1). [Figure: Systematic selection of studies] METHODOLOGY The selection criteria was similar to the method described in Vriens et al. (2017), which was used to construct the MOD-ENP-TOX nanotoxicity database. Exclusion criteria To specifically focus on adverse health effects of SiNPs, papers reporting on other interventions such as ecotoxicity, synergistic effects, SiNPs doped with other materials, and therapy-based outcomes were excluded. Inclusion criteria Papers reporting, - physico-chemical characteristics such as primary size, shape, composition, and crystallinity; - toxicological endpoints such as cytotoxicity, apoptosis/necrosis, genotoxicity, oxidative stress, immunotoxicity, and autophagy using immortalized cell lines or primary cells (experimental in vitro studies); and - toxic effects in laboratory-animals, more specifically in vivo experiments using rats and mice. Literature search We searched two databases for papers published from June 2010 (after Napierska et al. 2010) to December 2016. In the PubMed “http://www.ncbi.nlm.nih.gov/PubMed” and EMBASE “https://www.embase.com” databases, the following keyword combinations were used: “silica nanoparticle” OR “silica NP” AND “toxicity” NOT “review”. We retrieved a list of 859 and 405 articles in English, respectively. In a second step, duplicates were removed and the titles were screened to identify studies that best matched with our search terms, leaving 611 relevant papers. In a third step, we excluded papers that met the exclusion criteria and left 128 most relevant papers. Finally, 82 papers reporting a minimum set of physico-chemical characterization and toxic effects were selected for the main content of the review. Notably, only one study was found on the toxicity of crystalline nanosilica (Chu et al. 2012), but it was finally excluded due to insufficient data on the size of particles. As a result, the review is dealing only with amorphous SiNPs. Induction of oxidative stress is considered as the major mechanism involved in SiNPs toxicity (Wang et al. 2009; Ye et al. 2010a, b) and, therefore, the in vitro section of the review was structured according to toxic endpoints and its association with oxidative stress. For in vivo, studies were sorted based on exposure route and modalities, since they can significantly influence the toxicokinetics of SiNPs. Throughout the review,

Read the complete text